TheraRadar
← Back
Data updated: Mar 29, 2026

ELITE LABS INC

Cardiovascular
Generics

ELITE LABS INC is a generic drug manufacturer focused on Cardiovascular.

1997
Since
15
Drugs
-
Trials
370
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

ROPINIROLE HYDROCHLORIDE 2026-01-22
Labeling
ROPINIROLE HYDROCHLORIDE 2026-01-22
Labeling
METHADONE HYDROCHLORIDE 2026-01-22
Manufacturing (CMC)
OXYCODONE AND ACETAMINOPHEN 2026-01-12
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2026-01-08
Labeling
OXYCODONE AND ACETAMINOPHEN 2026-01-06
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 100%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Novartis big-pharma
Cardiovascular
Merck big-pharma
Cardiovascular
Baxter specialty
Cardiovascular
Johnson & Johnson big-pharma
Cardiovascular
Bayer big-pharma
Cardiovascular